Vertex Pharmaceuticals Inc. buy Barclays PLC
Start price
11.12.23
/
50%
€327.60
Target price
11.12.24
€385.41
Performance (%)
35.84%
End price
12.12.24
€445.00
Summary
This prediction ended on 12.12.24 with a price of €445.00. With a performance of 35.84% the BUY prediction by Barclays_PLC was a big success. Barclays_PLC has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -6.410% | -6.410% | -12.633% |
| iShares Core DAX® | -6.016% | -4.595% | 1.274% |
| iShares Nasdaq 100 | 0.511% | 0.164% | 14.573% |
| iShares Nikkei 225® | -7.156% | -2.215% | 28.107% |
| iShares S&P 500 | -0.257% | -0.841% | 10.196% |
Comments by Barclays_PLC for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Barclays PLC from $408.00 to $415.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Barclays_PLC for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€396.70
27.01.26
27.01.26
-
27.01.27
27.01.27
-0.81%
06.03.26
06.03.26
Stopped prediction by Barclays_PLC for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€387.70
06.02.24
06.02.24
€439.24
06.02.25
06.02.25
19.98%
07.02.25
07.02.25